s.ferreira
TL2 · Coimbra
Contributes reviews on supplier material. Based in Coimbra.
Joined 19 October 2024 · last posted 1d
90 posts, newest first. Showing up to 150.
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #50 · Analytics › Mass spectrometry · 27 Jul 2026 · 4 likes Post #49 is the version of this I will quote in future. One addition. Small methodological point on 2 ppm match: repeating a measurement is cheap and resolves most of…
-
Private prescribing in the UK: what is actually involved Replied, post #74 · Regional › UK & Ireland · 24 Jul 2026 · 12 likes Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so themselves. I am describing what is, rather than arguing for…
-
Micro-titration: a disputed topic, argued properly Replied, post #106 · Practice › Dosing & titration · 17 Jul 2026 · 18 likes Answering the micro-titration question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
Asking a follow-up: new topic or new reply? Replied, post #45 · Start Here › How to Ask · 9 Jul 2026 · 32 likes If you are asking about a document, quote the exact wording of the line you are asking about. Paraphrasing a specification is how a discussion ends up about a document…
-
Revisiting: The best-written scientific paper you have read Replied, post #67 · Lounge › Off topic · 3 Jul 2026 · 3 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. If the premise is…
-
Designing a personal experiment that could change your mind — one year on Replied, post #64 · Research Methods › N-of-1 designs · 22 Jun 2026 · 3 likes That is a cleaner way of putting what I was circling around.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #43 · Analytics › HPLC & UHPLC · 15 Jun 2026 · 5 likes Area percent is a proportion of absorbance, not a proportion of mass. Two species with different extinction coefficients at the detection wavelength contribute…
-
Racemisation and why it is invisible to a mass measurement Replied, post #96 · Analytics › Impurities & related substances · 14 Jun 2026 · 0 likes Nobody has said the unglamorous part of racemisation yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Journal club: LEADER as the historical anchor Replied, post #87 · Evidence › Journal club · 10 Jun 2026 · 8 likes Post #83 put the caveat in the right place and I want to underline it. The arithmetic on LEADER is the easy part and it is where the errors are, which is an…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #15 · Start Here › Welcome · 10 Jun 2026 · 18 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #23 · Evidence › Journal club · 8 Jun 2026 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. I changed my mind about SURMOUNT-OSA after someone here asked me for the source and I could…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #19 · Start Here › Welcome · 8 Jun 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Talking to a therapist about this specifically Replied, post #9 · Wellbeing › Mental health · 1 Jun 2026 · 19 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative.
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #37 · Practice › Storage & stability · 22 May 2026 · 7 likes Everything in post #35 holds. The case it does not cover is the one I have. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #109 · Devices › Syringes & needles · 11 May 2026 · 2 likes Trying to state the 0.3 ml versus 0.5 ml position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #41 · Practice › Reconstitution · 10 May 2026 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Second pass at: When your prescriber and the evidence disagree Replied, post #19 · Clinical › Prescriber conversations · 8 May 2026 · 8 likes Source for the prescriber figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
-
Does a peptide degrade silently, with no visual change? Replied, post #18 · Practice › Storage & stability · 29 Apr 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. That is one…
-
Reimbursement variation across member states Started this topic · Regional › European Union · 29 Apr 2026 · 41 likes Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. Asking about reimbursement variation…
-
Journal club: is percentage weight change the right endpoint? Replied, post #97 · Evidence › Journal club · 23 Apr 2026 · 29 likes Picking up post #94: that is the part I would want checked first. The figures usually contain the finding and the text usually contains the interpretation. Separating…
-
Revisiting: Body image changing more slowly than the body Replied, post #3 · Wellbeing › Mental health · 17 Apr 2026 · 0 likes Practical note on Body image: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #95 · Sourcing › Vendor reports · 16 Apr 2026 · 2 likes Adding the measurement that post #92 says would settle it. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate…
-
Citation sweep results: how many references did not say what was claimed Replied, post #76 · Meta › Wiki maintenance · 12 Apr 2026 · 21 likes Building on post #73 rather than restating it. Taking citation sweep results seriously for a moment rather than deflecting: the honest position is that the community…
-
List price versus negotiated price versus what you pay Replied, post #42 · Access › Pricing · 11 Apr 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #35 · Evidence › Trials · 7 Apr 2026 · 2 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Choosing which test to pay for, given a fixed budget Replied, post #57 · Sourcing › Independent verification · 6 Apr 2026 · 5 likes Everything in post #55 holds. The case it does not cover is the one I have. Repeat determination on the same product line months apart is the measurement that speaks to…
-
Personal import allowances, compared — a second dataset Replied, post #85 · Access › International · 14 Mar 2026 · 0 likes I had written a reply contradicting post #81 and deleted it. Here is what survived. Licensed prescribing: where a compound is approved, prescribing is restricted to…
-
Revisiting: Maintainer handover: how it works Replied, post #33 · Meta › Wiki maintenance · 6 Mar 2026 · 4 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
-
Grapefruit: why this class is not the class that cares Replied, post #7 · Practice › Interactions · 3 Mar 2026 · 3 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Managing an unplanned gap in supply Replied, post #46 · Access › Shortages · 1 Mar 2026 · 7 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Bioimpedance and hydration: why the number moves Replied, post #12 · Outcomes › Body composition · 27 Feb 2026 · 2 likes Reading back through, this was answered upthread and I missed it. My fault.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #18 · Compounds › Tirzepatide · 17 Feb 2026 · 30 likes Everything in post #17 holds. The case it does not cover is the one I have. Research-use-only tirzepatide is not approved for human use and is not made to…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #27 · Outcomes › Body composition · 14 Feb 2026 · 0 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #56 · Documentation › Wiki requests · 26 Jan 2026 · 1 like On post #52 — agreed on the reasoning, with one qualification. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues,…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #24 · Data & Tools › Calculators · 16 Jan 2026 · 27 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #52 · Start Here › How to Ask · 13 Jan 2026 · 17 likes On post #50 — agreed on the reasoning, with one qualification. If you are asking about a document, quote the exact wording of the line you are asking about.…
-
Reading an interaction checker output critically Replied, post #85 · Practice › Interactions · 6 Jan 2026 · 12 likes A note on how reading an interaction checker output gets discussed rather than on reading an interaction checker output itself: the confident posts get the replies and…
-
Availability by country, dated, with primary sources — one year on Replied, post #10 · Access › International · 25 Dec 2025 · 12 likes A first-hand dated account for a region with thin coverage is worth more here than any summary, and the regions with thin coverage are most of them. Happy to be the one…
-
Prescription requirements and telehealth models Replied, post #66 · Sourcing › Regulatory · 14 Dec 2025 · 21 likes Summarising the prescription requirements and telehealth models thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has…
-
Tracking a preprint to publication: a worked example Replied, post #135 · Evidence › Preprints · 13 Dec 2025 · 4 likes No notes. Posting so the count is not one.
-
Filter needles: when they help and what they cost you Replied, post #2 · Devices › Syringes & needles · 8 Dec 2025 · 3 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
LOD and LOQ: definitions people get wrong Replied, post #2 · Analytics › Method validation · 18 Nov 2025 · 0 likes Precision has two levels worth distinguishing: repeatability within a run and intermediate precision across days, analysts and instruments. The second is where most…
-
The headache that turns out to be dehydration Replied, post #60 · Nutrition & Training › Hydration & electrolytes · 17 Nov 2025 · 8 likes That is consistent with mine, for whatever one more account is worth.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #123 · Safety › Adverse events · 12 Nov 2025 · 10 likes Everything in post #121 holds. The case it does not cover is the one I have. Nothing here is medical advice, and in this subcategory the phrase is doing more work than…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #114 · Practice › Storage & stability · 1 Nov 2025 · 15 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. None of the above is medical advice and…
-
Tracking that stops updating and then resumes Replied, post #35 · Sourcing › Logistics · 12 Oct 2025 · 0 likes Post #33 and I disagree about the size of the effect, not about the direction. Peak periods and public holidays affect this more than any other factor and are entirely…
-
Comparing my trajectory with the trial curves, carefully Replied, post #55 · Outcomes › Progress reports · 29 Sep 2025 · 0 likes Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not.
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #49 · Analytics › COA interpretation · 26 Sep 2025 · 0 likes Narrowing post #48, because the general version has more than one answer. An itemised related-substances table with retention times says considerably more about the…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #67 · Practice › Storage & stability · 22 Sep 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. That distinction has done more work for…
-
Severe abdominal pain: why this is not a forum question — one year on Replied, post #2 · Safety › Adverse events · 18 Sep 2025 · 6 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #122 · Evidence › Study critique · 16 Sep 2025 · 0 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
-
Asking about a compound your prescriber has not heard of Replied, post #135 · Clinical › Prescriber conversations · 23 Aug 2025 · 30 likes Everything in post #131 holds. The case it does not cover is the one I have. A question phrased as "what would you want to see before considering X" is answerable and…
-
Angle of injection and whether 90 degrees is always right Replied, post #7 · Practice › Administration · 4 Aug 2025 · 19 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #21 · Start Here › Welcome · 3 Aug 2025 · 0 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
-
How to research a compound with no human data without deceiving yourself Replied, post #34 · Compounds › Other compounds · 31 Jul 2025 · 2 likes Research a compound has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #85 · Compounds › Semaglutide · 24 Jul 2025 · 0 likes Post #83 describes the usual case. This is about the unusual one. Gallbladder events appear in the labelling for this class and are more common with larger, faster…
-
Asking about a compound your prescriber has not heard of Replied, post #100 · Clinical › Prescriber conversations · 20 Jul 2025 · 0 likes Post #96 put the caveat in the right place and I want to underline it. Bringing a record of symptoms with dates and severities makes an assessment materially easier and…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #2 · Compounds › Semaglutide · 20 Jun 2025 · 8 likes The opening post put the caveat in the right place and I want to underline it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction…
-
Why plausible mechanism is not evidence of effect Replied, post #14 · Compounds › Repair & healing peptides · 7 Jun 2025 · 19 likes Picking up post #11: that is the part I would want checked first. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral…
-
Pre-registering a personal experiment, seriously Replied, post #32 · Research Methods › N-of-1 designs · 28 May 2025 · 20 likes That reframing is the whole thing. The facts I already had.
-
Triple agonism: additive, synergistic, or neither? Replied, post #41 · Compounds › Retatrutide · 30 Apr 2025 · 1 like Where I part company with post #38, and it is a narrow parting. A request rather than an answer: could whoever has the primary source for triple agonism post it? I have…
-
Requesting a page: what makes a good request Replied, post #66 · Documentation › Wiki requests · 22 Apr 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #24 · Evidence › Journal club · 18 Apr 2025 · 12 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
About the Secretagogues & GH axis category Replied, post #6 · Compounds › Secretagogues & GH axis · 13 Apr 2025 · 20 likes That is consistent with mine, for whatever one more account is worth.
-
Sequence verification for an obscure compound: how it is done Replied, post #11 · Compounds › Other compounds · 12 Apr 2025 · 18 likes The version of sequence verification that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds,…
-
A supplier that answers analytical questions with restated claims Replied, post #53 · Sourcing › Red flags · 7 Apr 2025 · 12 likes Claims of pharmaceutical-grade status for research-use-only material are a labelling problem and are common enough to be worth expecting rather than reacting to. The…
-
Carryover and the ghost peak from last week's standard Replied, post #49 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
A certificate with no method stated: what can you conclude? Replied, post #18 · Analytics › COA interpretation · 2 Apr 2025 · 0 likes Worth separating two things that post #16 runs together. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #49 · Devices › Syringes & needles · 2 Apr 2025 · 0 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. That is…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #9 · Practice › Administration · 30 Mar 2025 · 0 likes Completing a dose: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #50 · Access › Insurance & coverage · 29 Mar 2025 · 12 likes I think the Coverage question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #14 · Compounds › Secretagogues & GH axis · 12 Mar 2025 · 8 likes CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #22 · Documentation › Doc review · 14 Feb 2025 · 1 like Confirming post #21 from a second method, which matters more than confirming it from a second person. On draft on reconstitution arithmetic I would separate what is…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #43 · Access › International · 14 Feb 2025 · 32 likes Adding the measurement that post #40 says would settle it. What would change my mind on Cross-border purchase within is a second dataset collected by someone with no…
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #6 · Clinical › Comorbidities · 26 Jan 2025 · 4 likes If someone has run Heart failure with preserved ejection properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #54 · Sourcing › Regulatory · 30 Dec 2024 · 0 likes The thing about Research-use-only labelling that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #32 · Compounds › Secretagogues & GH axis · 29 Dec 2024 · 7 likes The reason pulsatile secretion is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Converting between mg/mL and units per dose, both directions Replied, post #124 · Practice › Reconstitution · 10 Dec 2024 · 10 likes Post #123 is the version of this I will quote in future. One addition. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
-
[2026 update] New subcategory: rationale and scope Replied, post #37 · Meta › Announcements · 2 Dec 2024 · 2 likes I keep a log for New subcategory specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #27 · Clinical › Special populations · 25 Nov 2024 · 18 likes Two claims get bundled together under Athletes in weight-category sports and they need separating. The descriptive one — this is what was observed — is usually well…
-
Washout with a one-week half-life: the arithmetic Replied, post #5 · Research Methods › N-of-1 designs · 22 Nov 2024 · 20 likes Coming back to post #3, because the follow-up matters more than the original answer. The reason washout keeps being re-asked is that the answer is conditional and…
-
Revisiting: Moderation log format change Replied, post #19 · Meta › Announcements · 7 Nov 2024 · 0 likes Adding the measurement that post #18 says would settle it. Thank you for announcing it in advance rather than after. The number of places that do the reverse is…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #91 · Analytics › COA interpretation · 21 Oct 2024 · 19 likes Where two documents for the same lot disagree, the useful question is which was measured and which was transcribed. Most such disagreements are the second. A modest…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #52 · Analytics › Method validation · 15 Oct 2024 · 8 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #6 · Sourcing › Red flags · 15 Oct 2024 · 2 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
Progressive overload when the scale is falling — one year on Replied, post #150 · Nutrition & Training › Resistance training · 12 Oct 2024 · 16 likes Worth separating two things that post #146 runs together. The reports here that state the programme, the load and the timeframe are useful. The ones that state an…
-
US compounding rules and how they changed Replied, post #15 · Regional › North America · 7 Oct 2024 · 22 likes Post #12 answers the question as asked. The question underneath it is different. Date every claim in this subcategory. Positions here have moved repeatedly and old…
-
How to ask for a dose change without antagonising anyone Replied, post #15 · Clinical › Prescriber conversations · 16 Aug 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Promotion criteria, and the one that stops most nominations Replied, post #39 · Documentation › Doc review · 16 Aug 2024 · 6 likes Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document rather than the reverse.
-
Why I ask for the gradient before I discuss the number Replied, post #2 · Analytics › HPLC & UHPLC · 14 Jun 2024 · 1 like Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…